Versigent (NYSE:VGNT – Get Free Report) was upgraded by equities research analysts at Fox Advisors to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports.
A number of other equities research analysts also recently issued reports on VGNT. Wells Fargo & Company assumed coverage on Versigent in a research report on Monday. They issued an “overweight” rating and a $35.00 price objective on the stock. Royal Bank Of Canada began coverage on Versigent in a research note on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $31.50.
Check Out Our Latest Stock Report on VGNT
Versigent Trading Up 0.4%
Further Reading
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
